Speaker Profile
Ph.D., PHARMD, Deputy CEO & CSO, ALCEDIAG
Biography
Dinah Weissmann is Founder and CSO at Alcediag, a biotech company dedicated to the development of innovative diagnostics based on epigenetic biomarkers. Dinah is also co-Director of a public-private laboratory dedicated to the understanding the molecular basis of complex diseases. Her research field, mainly in neurosciences is dedicated to improve the conditions of patients suffering from mental disorders. Her last focus is the understanding of epigenetic mechanism impact on mood disorders and the development of blood tests to diagnose psychiatric conditions like depression and bipolar disorder. Her goal is to innovate to improve the patients quality of life .
Talk
RNA Editing Blood Biomarkers for Bipolar Diagnosis
The differential diagnosis of bipolar disorder and MDD is challenging, bipolar patients remain undiagnosed for years. Alcediag has developed blood biomarkers for mood disorder based on RNA editing and artificial intelligence. This panel of biomarkers was tested in two independent cohorts and show high performance in diagnosing bipolar patients.
Genomic Profiling Showcase:
ALCEDIAG
ALCEDIAG is an innovative diagnostic company specializing in the development and commercialization of blood tests, monitoring solutions, and companion diagnostics, primarily for mental health. These offerings are based upon the company’s distinctive expertise in epigenetics, RNA, and Artificial Intelligence, complemented by neurosciences and psychiatry.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Genomic Profiling Showcase will provide a 15-30 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.
